HD Insights Podcast
HD Insights Podcast
Huntington Study Group
Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger
47 minutes Posted Sep 24, 2020 at 11:00 am.
0:00
47:11
Download MP3
Show notes

Dr. Dietrich Haubenberger, Medical Director at Neurocrine Biosciences, joined the HD Insights Podcast to talk about his work on the KINECT-HD study and his career journey to this point. KINECT-HD is a Phase 3, randomized, double-blind, placebo-controlled study investigating valbenazine for treatment of chorea in Huntington disease. The study is being conducted at sites across the U.S. and Canada. Additional information about the study can be found at www.KINECT-HD.org.